MétaCan
Menu
Back to cohort
Record W4281479043 · doi:10.2196/37929

Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study

2022· article· en· W4281479043 on OpenAlexvenueno aff
Joy Burns, Patrick Rivers, Lindsay LeClair, Krystal S. Jovel, Ramona Rai, Ashley A. Lowe, Laura Edwards, Sana Khan, Clare Mathenge, Maria Ferraris, Jennifer L. Kuntz, Julie Mayo Lamberte, Kurt T. Hegmann, Marilyn J. Odean, Hilary McLeland-Wieser, Shawn C. Beitel, Leah Odame‐Bamfo, Natasha Schaefer Solle, Josephine Mak, Andrew L. Phillips, Brian Sokol, James Hollister, Jezahel S. Ochoa, Lauren Grant, Matthew S. Thiese, Keya B Jacoby, Karen Lutrick, Felipe A Pubillones, Young M. Yoo, Danielle Rentz Hunt, Katherine Ellingson, Mark Berry, Joe K. Gerald, Joanna Lopez, Lynn B. Gerald, Meredith G. Wesley, Karl Krupp, Meghan K. Herring, Purnima Madhivanan, Alberto J. Caban‐Martinez, Harmony L. Tyner, Jennifer K. Meece, Sarang K. Yoon, Ashley Fowlkes, Allison L. Naleway, Lisa Gwynn, Jefferey L. Burgess, Mark G. Thompson, Lauren E.W. Olsho, Manjusha Gaglani

Bibliographic record

VenueJMIR Research Protocols · 2022
Typearticle
Languageen
FieldMedicine
TopicRespiratory viral infections research
Canadian institutionsnot available
FundersNational Center for Advancing Translational Sciences
KeywordsMedicineFamily medicineIncidence (geometry)Longitudinal studyCohortAttritionTimelineEpidemiologyCohort studyVaccinationProspective cohort studyEnvironmental healthPediatrics

Abstract

fetched live from OpenAlex

BACKGROUND: Assessing the real-world effectiveness of COVID-19 vaccines and understanding the incidence and severity of SARS-CoV-2 illness in children are essential to inform policy and guide health care professionals in advising parents and caregivers of children who test positive for SARS-CoV-2. OBJECTIVE: This report describes the objectives and methods for conducting the Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT) study. PROTECT is a longitudinal prospective pediatric cohort study designed to estimate SARS-CoV-2 incidence and COVID-19 vaccine effectiveness (VE) against infection among children aged 6 months to 17 years, as well as differences in SARS-CoV-2 infection and vaccine response between children and adolescents. METHODS: The PROTECT multisite network was initiated in July 2021, which aims to enroll approximately 2305 children across four US locations and collect data over a 2-year surveillance period. The enrollment target was based on prospective power calculations and accounts for expected attrition and nonresponse. Study sites recruit parents and legal guardians of age-eligible children participating in the existing Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance (HEROES)-Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER) network as well as from surrounding communities. Child demographics, medical history, COVID-19 exposure, vaccination history, and parents/legal guardians' knowledge and attitudes about COVID-19 are collected at baseline and throughout the study. Mid-turbinate nasal specimens are self-collected or collected by parents/legal guardians weekly, regardless of symptoms, for SARS-CoV-2 and influenza testing via reverse transcription-polymerase chain reaction (RT-PCR) assay, and the presence of COVID-like illness (CLI) is reported. Children who test positive for SARS-CoV-2 or influenza, or report CLI are monitored weekly by online surveys to report exposure and medical utilization until no longer ill. Children, with permission of their parents/legal guardians, may elect to contribute blood at enrollment, following SARS-CoV-2 infection, following COVID-19 vaccination, and at the end of the study period. PROTECT uses electronic medical record (EMR) linkages where available, and verifies COVID-19 and influenza vaccinations through EMR or state vaccine registries. RESULTS: Data collection began in July 2021 and is expected to continue through the spring of 2023. As of April 13, 2022, 2371 children are enrolled in PROTECT. Enrollment is ongoing at all study sites. CONCLUSIONS: As COVID-19 vaccine products are authorized for use in pediatric populations, PROTECT study data will provide real-world estimates of VE in preventing infection. In addition, this prospective cohort provides a unique opportunity to further understand SARS-CoV-2 incidence, clinical course, and key knowledge gaps that may inform public health. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/37929.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.067
metaresearch head score (Gemma)0.048
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.067
Threshold uncertainty score0.353

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0670.048
Meta-epidemiology (narrow)0.0040.003
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0030.004
Science and technology studies0.0060.002
Scholarly communication0.0030.003
Open science0.0030.003
Research integrity0.0040.006
Insufficient payload (model declined to judge)0.0470.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.584
GPT teacher head0.658
Teacher spread0.074 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations12
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJMIR Research ProtocolsSame topicRespiratory viral infections researchFrench-language works237,207